Abstract
Osmium carbonyl clusters, especially the cluster [Os3(CO) 10-(NCCH3)2], were found to be active against four cancer cell lines, namely, ER+ breast carcinoma (MCF-7), ER- breast carcinoma (MDA-MB-231), metastatic colorectal adenocarcinoma (SW620), and hepatocarcinoma (Hep G2). The mode of action was studied in MCF-7 and MDA-MB-231 cell lines by a number ofmorpho logical and apoptosis assays, all ofwhich pointed to the induction of apoptosis.
Original language | English |
---|---|
Pages (from-to) | 1269-1275 |
Number of pages | 7 |
Journal | ChemMedChem |
Volume | 3 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 18 2008 |
Externally published | Yes |
ASJC Scopus Subject Areas
- Biochemistry
- Molecular Medicine
- Pharmacology
- Drug Discovery
- General Pharmacology, Toxicology and Pharmaceutics
- Organic Chemistry
Keywords
- Antitumor agents
- Apoptosis
- Cancer
- Cluster compounds
- Osmium